Back to Authors

Serzan, Michael Thomas

0000-0001-6453-8035

Mayo Clinic

Dana-Farber Cancer Institute, Boston, MA.

Citations 2

Systemic Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: ASCO Living Guideline, Version 2026.1.4
Taplin, Mary‐Ellen , Rumble, R. Bryan , Naqvi, Syed Arsalan Ahmed , Nahhat, Fouad , Dias, Mariane Sousa Fontes , Hope, Thomas A. , He, Huan, Hotte, Sebastién J. , Emamekhoo, Hamid , Celano, Paul, Kungel, Terry M. , Hentzen, Steve, Marzalik, Jacob S. , Parikh, Rahul A , Rumble, R Bryan , Nahhat, Fouad , Dias, Mariane Fontes , Hope, Thomas A , Hotte, Sebastien J , Emamekhoo, Hamid , Murad, M Hassan , Hentzen, Steve , Marzalik, Jacob S , Serzan, Michael Thomas , Riaz, Irbaz B , Taplin, Mary-Ellen , He, Huan, Murad, M. Hassan , Celano, Paul , Serzan, Michael , Riaz, Irbaz Bin

Journal of Clinical Oncology | August 6, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1200/jco-26-01898 Get It

This guideline has been updated. This ASCO Living Guideline is reviewed on an eight-week cycle. Please see the online dynamic version for the latest updates. Living guidelines are developed for selected topic areas with rapidly evolving evidence that drives frequent change in recommended clinical practice. Living guidelines are updated on a regular schedule by a standing expert panel that systematically reviews the health literature on a continuous basis, as described in the ASCO Guidelines Methodology Manual . ASCO Living Guidelines follow the ASCO Conflict of Interest Policy Implementation for Clinical Practice Guidelines . Living Guidelines and updates are not intended to substitute for independent professional judgment of the treating clinician and do not account for individual variation among patients. See appendix for disclaimers and other important information (Appendix I and Appendix II). Updates are published regularly and can be found on the ASCO Publications website .
Systemic Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer: ASCO Living Guideline, Version 2026.1
Taplin, Mary-Ellen, Riaz, Irbaz Bin , Rumble, R. Bryan , Naqvi, Syed Arsalan Ahmed , Hope, MD Thomas A., Dias, Mariane Fontes , He, Huan, Hotte, Sebastién J. , Emamekhoo, Hamid, Murad, M. Hassan, Celano, Paul , Kungel, Terry M. , Hentzen, Steve, Serzan, Michael , Parikh, Rahul A., Murad, M. Hassan , Hope, Thomas A. , Emamekhoo, Hamid , Dias, Mariane Sousa Fontes , Hope, Thomas A , Emamekhoo, Hamid , Murad, M Hassan , Serzan, Michael Thomas , Parikh, Rahul A , He, Huan , Riaz, Irbaz B , Hotte, Sebastien J , Rumble, R Bryan , Taplin, Mary‐Ellen , Kungel, Terry

Journal of Clinical Oncology | January 20, 2026 | Volume: 44 | Issue: 6 | Pages: No page available

10.1200/jco-25-02693 Get It

This guideline has been updated. This ASCO Living Guideline is reviewed on an eight-week cycle. Please see the online dynamic version for the latest updates. Living guidelines are developed for selected topic areas with rapidly evolving evidence that drives frequent change in recommended clinical practice. Living guidelines are updated on a regular schedule by a standing expert panel that systematically reviews the health literature on a continuous basis, as described in the ASCO Guidelines Methodology Manual . ASCO Living Guidelines follow the ASCO Conflict of Interest Policy Implementation for Clinical Practice Guidelines . Living Guidelines and updates are not intended to substitute for independent professional judgment of the treating clinician and do not account for individual variation among patients. See appendix for disclaimers and other important information ( Appendix 1 and Appendix 2 ). Updates are published regularly and can be found at www.asco.org/genitourinary-cancer-guidelines .